David Mehalick

Insider Reports History

Entity
Individual
Location
5000 Tressdale Drive, Gibsonia, PA
Signature
/s/ David Mehalick
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Mehalick:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Coeptis Therapeutics Holdings, Inc. CEO and President, Director, 10%+ Owner Common Stock 2.78M $1.61M $0.58 Jan 8, 2024 Direct
Coeptis Therapeutics Inc. CEO and President, Director, 10%+ Owner Common Stock 1.8M Nov 16, 2021 Direct
Coeptis Therapeutics Holdings, Inc. CEO and President, Director, 10%+ Owner Non-qualified Stock Options (right to buy) 375K Jan 27, 2023 Direct
Coeptis Therapeutics Holdings, Inc. CEO and President, Director, 10%+ Owner Incentive Stock Options (right to buy) 250K Jan 27, 2023 Direct

Insider Reports Filed by David Mehalick

Symbol Company Period Transactions Value $ Form Type Date Filed Role
COEP Coeptis Therapeutics Holdings, Inc. Jan 5, 2024 3 $16.7K 4 Jan 9, 2024 CEO and President, Director, 10%+ Owner
COEP Coeptis Therapeutics Holdings, Inc. Dec 7, 2023 1 $0 4 Dec 11, 2023 CEO and President, Director, 10%+ Owner
COEP Coeptis Therapeutics Holdings, Inc. Jan 27, 2023 2 $0 4 Jan 31, 2023 CEO and President, Director, 10%+ Owner
COEP Coeptis Therapeutics Holdings, Inc. Oct 28, 2022 0 $0 3 Nov 7, 2022 CEO and President, Director, 10%+ Owner
COEP Coeptis Therapeutics Inc. Nov 16, 2021 1 $0 4 Nov 18, 2021 CEO and President, Director, 10%+ Owner